Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples